Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Testing effectiveness (Phase 2)Looking for participantsNCT06189495
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicableLooking for participantsNCT01776398
What this trial is testing

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more
Weill Medical College of Cornell University 2,000
Large-scale testing (Phase 3)Study completedNCT02597933
What this trial is testing

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 580
Testing effectiveness (Phase 2)Ended earlyNCT02745145
What this trial is testing

Abituzumab in SSc-ILD

Who this might be right for
Systemic Sclerosis-associated Interstitial Lung Disease
EMD Serono Research & Development Institute, Inc. 24
Large-scale testing (Phase 3)UnknownNCT03856853
What this trial is testing

Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis-associated Interstitial Lung Disease (Ssc-ild)
Beijing Continent Pharmaceutical Co, Ltd. 144
Not applicableEnrolling By InvitationNCT06472362
What this trial is testing

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Who this might be right for
Systemic Sclerosis
Royal Brompton & Harefield NHS Foundation Trust 1,000
Not applicableUnknownNCT03858842
What this trial is testing

Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017

Who this might be right for
Lung Diseases, InterstitialLung Disease With Systemic Sclerosis
Hospices Civils de Lyon 100
Not applicableStudy completedNCT04325217
What this trial is testing

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 586
Post-approval studies (Phase 4)Looking for participantsNCT07087912
What this trial is testing

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital 477
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Not applicableActive Not RecruitingNCT07080125
What this trial is testing

A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

Who this might be right for
Interstitial Lung DiseasesSystemic Sclerosis Associated Interstitial Lung Disease
Boehringer Ingelheim 2,000
30